CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-14 | Carmichael Gordon Director | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 | ||
| 2024-08-14 | Ma Songjiang President | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2024-08-14 | Eastling Thomas Wilson Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2024-08-14 | Luo Ying Director | Grant or award · Stock Option (Right to Buy) | +26,000 | 26,000 | ||
| 2024-08-14 | Chen Ruoyu Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-08-14 | Ying Han Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +341,000 | 341,000 | ||
| 2024-08-06 | Epstein David M. Director | Grant or award · Stock Option (Right to Buy) | +1,866 | 1,866 | ||
| 2024-06-28 | USMAN NASSIM Director | Option exercise 10b5-1 | +3,452 | $6.93 | $24K | 5,088 |
| 2024-06-28 | USMAN NASSIM Director | Sale 10b5-1 | −3,452 | $12.00 | $41K | 1,636 |
| 2024-06-28 | USMAN NASSIM Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,452 | 278,200 | ||
| 2024-05-01 | USMAN NASSIM Director | Option exercise 10b5-1 | +20,000 | $6.93 | $139K | 21,636 |
| 2024-05-01 | USMAN NASSIM Director | Sale 10b5-1 | −14,900 | $13.86 | $207K | 6,736 |
| 2024-05-01 | USMAN NASSIM Director | Sale 10b5-1 | −5,000 | $14.90 | $75K | 1,736 |
| 2024-05-01 | USMAN NASSIM Director | Sale 10b5-1 | −100 | $15.63 | $2K | 1,636 |
| 2024-05-01 | USMAN NASSIM Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 281,652 | ||
| 2024-04-01 | USMAN NASSIM Director | Option exercise 10b5-1 | +20,000 | $6.93 | $139K | 21,636 |
| 2024-04-01 | USMAN NASSIM Director | Sale 10b5-1 | −20,000 | $16.15 | $323K | 1,636 |
| 2024-04-01 | USMAN NASSIM Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 301,652 | ||
| 2024-03-20 | Nussbaum Rodney L Director | Grant or award · Stock Option (Right to Buy) | +1,866 | 1,866 | ||
| 2024-03-15 | USMAN NASSIM Director | Option exercise 10b5-1 | +20,000 | $6.93 | $139K | 21,636 |
Page 10 of 11 · 215 trades